Global Market Study on Active Pharmaceutical Ingredients: Pharmaceutical Companies to Lead Market Growth

May 2021| PMR280C| Persistence Market Research

Sample Report

Report Highlights

Active Pharmaceutical Ingredient Market- Scope of Report

A latest publication by Persistence Market Research on the global active pharmaceutical ingredient market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for successful growth of the active pharmaceutical ingredient market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers to know the demand for active pharmaceutical ingredients and the quantitative development opportunities during the study period.

The research is beneficial for manufacturers of active pharmaceutical ingredients, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the active pharmaceutical ingredient market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the active pharmaceutical ingredient industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the active pharmaceutical ingredient market offers information divided into three important segments — API, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

API

Small Molecules
Controlled Substances
Natural Opioids
Semi-synthetic/Synthetic Opioids
Non-Controlled Substances
NSAIDs
Anti-infective
Antimicrobial
Oral anti-diabetics
Anti-hypertensive
Others

HPAPI

Peptides & Oligonucleotides
Carbohydrate Drugs
Steroidal Drugs

End User

Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Contract Development Manufacturing Organizations (CDMOs)
Compounding Pharmacies

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for active pharmaceutical ingredients over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the active pharmaceutical ingredient market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can businesses in the active pharmaceutical ingredient market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the active pharmaceutical ingredient market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the active pharmaceutical ingredient market more accurate and reliable.

Table 1 : Global Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 2 : Global Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 3 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 4 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 5 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 6 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 7 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 8 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 9 : South Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 10 : South Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 11 : East Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 12 : East Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 13 : Oceania Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 14 : Oceania Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 15 : MEA Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
Table 16 : MEA Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 17 : Global Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 18 : Global Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 19 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 20 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 21 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 22 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 23 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 24 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 25 : South Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 26 : South Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 27 : East Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 28 : East Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 29 : Oceania Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 30 : Oceania Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 31 : MEA Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
Table 32 : MEA Active Pharmaceutical Ingredient Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type

Figure 1 : Global Active Pharmaceutical Ingredient Market Value (US$ Bn) by API Type, 2021 & 2031
Figure 2 : Global Active Pharmaceutical Ingredient Market Value Analysis (US$ Bn), 2016-2020
Figure 3 : Global Active Pharmaceutical Ingredient Market Value Forecast (US$ Bn), 2021-2031
Figure 4 : Global Active Pharmaceutical Ingredient Market Absolute $ Opportunity, 2021-2031
Figure 5 : Global Active Pharmaceutical Ingredient Market Share Analysis (%) by API Type, 2021 & 2031
Figure 6 : Global Active Pharmaceutical Ingredient Market Y-o-Y Growth (%) by, 2020-2031
Figure 7 : Global Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 8 : Global Active Pharmaceutical Ingredient Market Share Analysis (%) by End User, 2021 & 2031
Figure 9 : Global Active Pharmaceutical Ingredient Market Y-o-Y Growth (%) by End User, 2020-2031
Figure 10 : Global Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User, 2021-2031
Figure 11 : Global Active Pharmaceutical Ingredient Market Share Analysis (%) by Country, 2021 & 2031
Figure 12 : Global Active Pharmaceutical Ingredient Market Y-o-Y Growth (%) by Country, 2021-2031
Figure 13 : Global Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 14 : North America Active Pharmaceutical Ingredient Market Value Share, By API Type, 2021 (E)
Figure 15 : North America Active Pharmaceutical Ingredient Market Value Share, By End User, 2021 (E)
Figure 16 : North America Market Value Share, By Country, 2021 (E)
Figure 17 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn), 2016 - 2020
Figure 18 : North America Active Pharmaceutical Ingredient Market Value (US$ Bn) Forecast, 2021-2031
Figure 19 : North America Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 20 : North America Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User , 2021-2031
Figure 21 : North America Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 22 : Latin America Active Pharmaceutical Ingredient Market Value Share, By API Type, 2021 (E)
Figure 23 : Latin America Active Pharmaceutical Ingredient Market Value Share, By End User, 2021 (E)
Figure 24 : Latin America Market Value Share, By Country, 2021 (E)
Figure 25 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn), 2016 - 2020
Figure 26 : Latin America Active Pharmaceutical Ingredient Market Value (US$ Bn) Forecast, 2021-2031
Figure 27 : Latin America Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 28 : Latin America Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User , 2021-203128
Figure 29 : Latin America Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 30 : Europe Active Pharmaceutical Ingredient Market Value Share, By API Type, 2021 (E)
Figure 31 : Europe Active Pharmaceutical Ingredient Market Value Share, By End User, 2021 (E)
Figure 32 : Europe Market Value Share, By Country, 2021 (E)
Figure 33 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn), 2016 - 2020
Figure 34 : Europe Active Pharmaceutical Ingredient Market Value (US$ Bn) Forecast, 2021-2031
Figure 35 : Europe Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 36 : Europe Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User , 2021-2031
Figure 37 : Europe Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 38 : South Asia Active Pharmaceutical Ingredient Market Value Share, By API Type, 2021 (E)
Figure 39 : South Asia Active Pharmaceutical Ingredient Market Value Share, By End User, 2021 (E)
Figure 40 : South Asia Market Value Share, By Country, 2021 (E)
Figure 41 : South Asia Active Pharmaceutical Ingredient Market Value (US$ Bn), 2016 - 2020
Figure 42 : South Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Forecast, 2021-2031
Figure 43 : South Asia Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 44 : South Asia Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User , 2021-2031
Figure 45 : South Asia Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 46 : East Asia Active Pharmaceutical Ingredient Market Value Share, By API Type, 2021 (E)
Figure 47 : East Asia Active Pharmaceutical Ingredient Market Value Share, By End User, 2021 (E)
Figure 48 : East Asia Market Value Share, By Country, 2021 (E)
Figure 49 : East Asia Active Pharmaceutical Ingredient Market Value (US$ Bn), 2016 - 2020
Figure 50 : East Asia Active Pharmaceutical Ingredient Market Value (US$ Bn) Forecast, 2021-2031
Figure 51 : East Asia Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 52 : East Asia Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User , 2021-2031
Figure 53 : East Asia Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 54 : Oceania Active Pharmaceutical Ingredient Market Value Share, By API Type, 2021 (E)
Figure 55 : Oceania Active Pharmaceutical Ingredient Market Value Share, By End User, 2021 (E)
Figure 56 : Oceania Market Value Share, By Country, 2021 (E)
Figure 57 : Oceania Active Pharmaceutical Ingredient Market Value (US$ Bn), 2016 - 2020
Figure 58 : Oceania Active Pharmaceutical Ingredient Market Value (US$ Bn) Forecast, 2021-2031
Figure 59 : Oceania Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 60 : Oceania Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User , 2021-2031
Figure 61 : East Asia Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 62 : MEA Active Pharmaceutical Ingredient Market Value Share, By API Type, 2021 (E)
Figure 63 : MEA Active Pharmaceutical Ingredient Market Value Share, By End User, 2021 (E)
Figure 64 : MEA Market Value Share, By Country, 2021 (E)
Figure 65 : MEA Active Pharmaceutical Ingredient Market Value (US$ Bn), 2016 - 2020
Figure 66 : MEA Active Pharmaceutical Ingredient Market Value (US$ Bn) Forecast, 2021-2031
Figure 67 : MEA Active Pharmaceutical Ingredient Market Attractiveness Analysis by API Type, 2021-2031
Figure 68 : MEA Active Pharmaceutical Ingredient Market Attractiveness Analysis by End User , 2021-2031
Figure 69 : MEA Active Pharmaceutical Ingredient Market Attractiveness Analysis by Country, 2021-2031
Figure 70 : U.S. Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 71 : U.S. Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 72 : Global Vs. U.S. Growth Comparison
Figure 73 : Canada Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 74 : Canada Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 75 : Global Vs. Canada Growth Comparison
Figure 76 : Mexico Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 77 : Mexico Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 78 : Global Vs. Mexico Growth Comparison
Figure 79 : Brazil Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 80 : Brazil Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 81 : Global Vs. Brazil Growth Comparison
Figure 82 : U.K. Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 83 : U.K. Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 84 : Global Vs. U.K. Growth Comparison
Figure 85 : Germany Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 86 : Germany Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 87 : Global Vs. Germany Growth Comparison
Figure 88 : France Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 89 : France Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 90 : Global Vs. France Growth Comparison
Figure 91 : Italy Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 92 : Italy Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 93 : Global Vs. Italy Growth Comparison
Figure 94 : Spain Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 95 : Spain Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 96 : Global Vs. Spain Growth Comparison
Figure 97 : Russia Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 98 : Russia Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 99 : Global Vs. Russia Growth Comparison
Figure 100 : China Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 101 : China Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 102 : Global Vs. China Growth Comparison
Figure 103 : Japan Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 104 : Japan Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 105 : Global Vs. Japan Growth Comparison
Figure 106 : South Korea Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 107 : South Korea Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 108 : Global Vs. South Korea Growth Comparison
Figure 109 : India Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 110 : India Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 111 : Global Vs. India Growth Comparison
Figure 112 : Thailand Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 113 : Thailand Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 114 : Global Vs. Thailand Growth Comparison
Figure 115 : Indonesia Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 116 : Indonesia Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 117 : Global Vs. Indonesia Growth Comparison
Figure 118 : Malaysia Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 119 : Malaysia Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 120 : Global Vs. Malaysia Growth Comparison
Figure 121 : Australia Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 122 : Australia Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 123 : Global Vs. Australia Growth Comparison
Figure 124 : New Zealand Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 125 : New Zealand Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 126 : Global Vs. New Zealand Growth Comparison
Figure 127 : GCC Countries Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 128 : GCC Countries Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 129 : Global Vs. GCC Countries Growth Comparison
Figure 130 : Turkey Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 131 : Turkey Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 132 : Global Vs. Turkey Growth Comparison
Figure 133 : South Africa Active Pharmaceutical Ingredient Market Share Analysis (%), By Product Type, 2020 &2031
Figure 134 : South Africa Active Pharmaceutical Ingredient Market Share Analysis (%), By End User, 2020 &2031
Figure 135 : Global Vs. South Africa Growth Comparison

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Similar Reports from Persistence Market Research

Global Market Study on Active Pharmaceutical Ingredients: Growing Prevalence of Chronic Disorders Increasing Demand for Pharmaceuticals & APIs

Published Date - Mar 2021
Report Code - PMR280B

Active Pharmaceutical Ingredients (API) Market - Scope of Report

A latest, revised publication by Persistence Market Research on the global active pharmaceutical ingredients (API) market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and ...